Luis Felipe Espinal Pérez

Luis Felipe Espinal Pérez

Auto-generated profile, based on publicly available information

Luis Felipe Espinal Pérez


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
AVAbigail Berenice Gómez Valenzuela
Abigail Berenice Gómez Valenzuela
JAJorge Reynaldo Ayala Aguilar
Jorge Reynaldo Ayala Aguilar
ARAndré Ayala Rodríguez
André Ayala Rodríguez
STStephanie Paola Feijóo Tapia
Stephanie Paola Feijóo Tapia
KCKevin Alexander Achig Carrion
Kevin Alexander Achig Carrion
CBCristian Israel Sarmiento Bonilla
Cristian Israel Sarmiento Bonilla
Lymphedema is a chronic and progressive disorder resulting from impaired lymphatic transport, leading to fluid accumulation, chronic inflammation, fibrosis, and progressive functional impairment. Recent advances in reconstructive surgery have shifted therapeutic strategies from symptom control toward physiological restoration of lymphatic drainage through supermicrosurgical techniques. This review analyzes the current scientific evidence regarding supermicrosurgery and lymphatic reconstruction, emphasizing lymphaticovenous anastomosis, vascularized lymph node transfer, immediate lymphatic reconstruction, advanced diagnostic imaging, and emerging regenerative medicine approaches. Contemporary literature demonstrates that individualized patient selection, supported by indocyanine green lymphography and other imaging modalities, is fundamental for optimizing surgical outcomes. Physiological reconstruction has been associated with reductions in limb volume, lower incidence of cellulitis, improved functional recovery, decreased dependence on compression therapy, and better quality of life when integrated into multidisciplinary care. Emerging technologies, including tissue engineering, therapeutic lymphangiogenesis, artificial intelligence, and image-guided surgery, are expanding future therapeutic possibilities while promoting increasingly personalized treatment strategies. Although current evidence supports the effectiveness of physiological lymphatic reconstruction, further multicenter prospective studies with standardized methodologies are required to strengthen clinical recommendations and improve the global implementation of these techniques. Overall, supermicrosurgery represents a major milestone in modern reconstructive surgery and continues to redefine the management of primary and secondary lymphedema through innovation, technological development, and international multidisciplinary collaboration.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
MQMiguel Horacio Quijano
Miguel Horacio Quijano
BIBenitez Barrios Sosimo Isaac
Benitez Barrios Sosimo Isaac
ALAndres Mauricio Jaimes Lázaro
Andres Mauricio Jaimes Lázaro
Robinson Alexander Morey ContrerasRobinson Alexander Morey Contreras
Robinson Alexander Morey Contreras
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
JSJoseph Rodríguez Sánchez
Joseph Rodríguez Sánchez
The vaginal microbiome has emerged as a fundamental determinant of female reproductive health and a promising therapeutic target for the prevention and management of gynecological and obstetric complications. This review aimed to critically analyze the current scientific evidence regarding emerging microbiome-targeted therapeutic approaches, emphasizing their biological mechanisms, clinical effectiveness, therapeutic potential, and future applications in personalized reproductive medicine. A structured narrative review based on the Scientific Method was conducted using publications retrieved from internationally recognized databases, including PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, Nature Portfolio, and Google Scholar. Recent evidence demonstrates that vaginal dysbiosis is strongly associated with bacterial vaginosis, recurrent vulvovaginal candidiasis, infertility, recurrent urinary tract infections, preterm birth, and other adverse pregnancy outcomes. The analyzed literature indicates that probiotics currently possess the strongest clinical evidence, while live biotherapeutic products, vaginal microbiota transplantation, postbiotics, prebiotics, and advanced vaginal drug delivery systems represent rapidly evolving therapeutic alternatives with considerable potential for restoring microbial homeostasis. These interventions extend beyond pathogen elimination by promoting immune regulation, epithelial barrier integrity, long-term microbial stability, and personalized therapeutic strategies. Although important methodological limitations remain, including heterogeneity among studies and limited long-term clinical data, microbiome-directed therapies are expected to play an increasingly significant role in precision reproductive medicine. Continued multidisciplinary research and high-quality clinical trials will be essential to facilitate their safe and effective integration into routine gynecological and obstetric practice.
1

30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
JVJocelyne Keren Hinojosa Villanueva
Jocelyne Keren Hinojosa Villanueva
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
JSJuan José Vergara Serpa
Juan José Vergara Serpa
SPSaimart Trinidad Contreras Ponce
Saimart Trinidad Contreras Ponce
GJGary Bastian Medina Jimenez
Gary Bastian Medina Jimenez
ANAlexa Fernanda Uriostegui Navarro
Alexa Fernanda Uriostegui Navarro
Systemic diseases may present with cutaneous, neurological, or psychiatric manifestations before the classical diagnostic phenotype becomes fully established, creating a clinically relevant prediagnostic window. This study analyzed the main neuropsychiatric and cutaneous manifestations associated with systemic lupus erythematosus, Sjögren syndrome, Behçet disease, sarcoidosis, antiphospholipid syndrome, and systemic vasculitis, with emphasis on their temporal relationship with definitive diagnosis and their potential value as early warning signs. An integrative literature review based on the scientific method was conducted using evidence obtained from PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. The analysis considered the type of systemic disease, cutaneous findings, neurological or psychiatric manifestations, predominant pathophysiological mechanisms, and timing in relation to diagnosis. The reviewed evidence showed that systemic lupus erythematosus presented the broadest clinical heterogeneity, while neurological manifestations in Sjögren syndrome may precede classical glandular symptoms. Recurrent mucosal ulceration was particularly relevant in Behçet disease, granulomatous skin lesions provided diagnostic support in sarcoidosis, and vascular skin abnormalities were associated with neurological ischemic events in antiphospholipid syndrome and systemic vasculitis. The most recurrent mechanisms included autoimmune-inflammatory, vascular-thrombotic, vasculitic, and granulomatous pathways. Clinically relevant combinations included purpura with peripheral neuropathy, livedoid skin changes with cerebrovascular events, recurrent mucosal ulceration with neurological inflammation, photosensitive lesions with neuropsychiatric abnormalities, and granulomatous skin disease with neurological involvement. These findings indicate that isolated manifestations have limited specificity, whereas coherent multisystem patterns may increase suspicion of an underlying systemic disorder. Integrating dermatological and neuropsychiatric findings into multidisciplinary clinical assessment may contribute to earlier diagnostic recognition and reduce delays before significant organ involvement develops.

30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
PGPaola Marisol Santa Cruz González
Paola Marisol Santa Cruz González
MMMaría Cristina Martínez Mazón
María Cristina Martínez Mazón
ADAnabel Stephanny Ortiz Dávila
Anabel Stephanny Ortiz Dávila
EPEsteban Fernando Torres Perez
Esteban Fernando Torres Perez
IGIgnacio Arturo Salazar Garcia
Ignacio Arturo Salazar Garcia
Chronic dermatological diseases are increasingly understood as systemic disorders influenced by interactions among cutaneous and intestinal microbiota, immune regulation, psychological stress, and neuroendocrine signaling. This study analyzed the gut–skin–brain axis as an integrative framework for understanding the pathophysiology of psoriasis, atopic dermatitis, acne, and rosacea. An integrative literature review structured according to the Scientific Method was conducted, incorporating evidence concerning intestinal and cutaneous dysbiosis, epithelial barrier alterations, microbial metabolites, systemic inflammation, psychological stress, hypothalamic–pituitary–adrenal axis activation, autonomic signaling, neuroimmune mechanisms, sleep disturbances, and quality of life. The analysis identified systemic inflammation as the most consistently represented connecting domain across the reviewed evidence. Microbiota-related studies frequently incorporated immune and inflammatory pathways, whereas psychological and neuroendocrine research also demonstrated substantial overlap with inflammatory mechanisms and clinical manifestations. Psoriasis showed a strong representation of microbiota and systemic inflammatory pathways; atopic dermatitis demonstrated prominent interactions among barrier dysfunction, microbial alterations, pruritus, immune activation, and stress; acne showed a relatively balanced distribution among microbial, inflammatory, metabolic, and psychological mechanisms; and rosacea demonstrated relevant inflammatory, neurovascular, microbial, and psychological components. Direct integration of microbiome and psychological variables within the same investigations remained comparatively limited, revealing an important methodological gap. Overall, the findings support the gut–skin–brain axis as a multidirectional and disease-dependent framework rather than a fixed linear pathway. Microbial dysbiosis, inflammatory signaling, stress responses, and cutaneous manifestations appear to interact bidirectionally, although current evidence supports biological plausibility and association more strongly than definitive causality. Future longitudinal and interventional studies should simultaneously evaluate microbiome composition, inflammatory biomarkers, psychological variables, neuroendocrine function, sleep, and dermatological severity to clarify causal pathways and potential therapeutic targets.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
CAChristian Jason Ortiz Alvarez
Christian Jason Ortiz Alvarez
GYGustavo Adrián Pineda Yáñez
Gustavo Adrián Pineda Yáñez
AVAngie Xiomara Tapiero Villanueva
Angie Xiomara Tapiero Villanueva
SFSneyder Mauricio Quitiaquez Figueroa
Sneyder Mauricio Quitiaquez Figueroa
OMOscar Emmanuel Garcia Moreno
Oscar Emmanuel Garcia Moreno
MCMydolly Russell Palomeque Calle
Mydolly Russell Palomeque Calle
Extensive burn injuries represent a major challenge in contemporary medicine because of their complex interactions with systemic inflammation, immune dysfunction, infectious complications, and reconstructive requirements. Severe thermal injury disrupts skin barrier integrity and initiates profound immunological alterations involving innate and adaptive immune responses, creating conditions that may increase susceptibility to wound infection and systemic deterioration. This narrative review examines the immunopathological mechanisms associated with extensive burns, the microbiological characteristics of burn wound infections, and the clinical relevance of early surgical excision and reconstructive coverage. Scientific literature addressing burn pathophysiology, microbial colonization, invasive infection, antimicrobial resistance, skin grafting, and dermal substitutes was critically examined, incorporating international evidence and contributions from Latin America. The findings demonstrate that postburn immune dysfunction involves the coexistence of inflammatory activation and impaired antimicrobial defense, complicating the differentiation between sterile inflammation and infectious deterioration. Microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter species, and Enterobacterales remain clinically relevant, although their distribution varies according to institutional and geographical characteristics. Early excision of devitalized tissue and appropriate reconstructive coverage are fundamental components of burn management, particularly in patients with extensive tissue loss and limited donor-site availability. Nevertheless, differences in burn severity, surgical timing, and reported outcomes restrict direct comparisons between reconstructive techniques. The available evidence supports an integrated multidisciplinary approach combining immunological assessment, infection surveillance, antimicrobial stewardship, and individualized surgical management. Further multicenter investigations incorporating standardized clinical definitions, longitudinal immune monitoring, and consistent reconstructive outcomes are needed to optimize treatment strategies and improve survival, functional recovery, and long-term quality of life.

30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
LPLuis Felipe Espinal Pérez
Luis Felipe Espinal Pérez
MQMiguel Horacio Quijano
Miguel Horacio Quijano
JBJenny Mariela Reinoso Brito
Jenny Mariela Reinoso Brito
ABAbigail Macias Barraza
Abigail Macias Barraza
NCNathaly Freire Carrera
Nathaly Freire Carrera
SBSebastián Alfonso Duarte Baron
Sebastián Alfonso Duarte Baron
Body dysmorphic disorder (BDD) represents a significant challenge in aesthetic surgery because of its association with psychological distress, psychiatric comorbidity, unrealistic treatment expectations, and variable postoperative satisfaction. This narrative review aimed to critically examine international and Latin American scientific evidence regarding preoperative detection, psychiatric vulnerability, surgical outcomes, and safe patient selection among individuals seeking elective cosmetic procedures. A descriptive and analytical approach was adopted to synthesize 20 scientific publications, including observational studies, systematic reviews, meta-analyses, and clinical investigations addressing psychological assessment in aesthetic surgical settings. The reviewed evidence demonstrated considerable variability in BDD prevalence, with a meta-analysis reporting a pooled prevalence of 32.7% among rhinoplasty candidates and individual studies identifying higher proportions of dysmorphic symptoms in selected surgical populations. Preoperative screening instruments, including the Body Dysmorphic Disorder Questionnaire and its aesthetic adaptations, demonstrated clinical utility for identifying patients requiring additional psychological or psychiatric evaluation, although differences in diagnostic performance and population characteristics limited direct comparisons. Psychiatric comorbidity emerged as a relevant dimension, particularly regarding depressive disorders, obsessive-compulsive manifestations, and suicidality. Evidence concerning postoperative outcomes remained heterogeneous: while greater preoperative symptom severity was frequently associated with lower satisfaction, selected patients with mild to moderate dysmorphic symptoms experienced improvements following aesthetic procedures. Brazilian investigations provided relevant Latin American evidence concerning prevalence, functional characteristics, and postoperative evolution, although geographical representation remained limited. Overall, the findings support the integration of psychological screening, individualized psychiatric assessment, and multidisciplinary collaboration into aesthetic surgical decision-making. Further prospective and multicenter investigations are necessary to establish standardized assessment strategies, clarify predictors of postoperative psychological outcomes, and strengthen evidence-based criteria for safe patient selection.